1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane has been researched along with tamoxifen in 4 studies
Studies (1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane) | Trials (1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane) | Recent Studies (post-2010) (1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
5 | 0 | 0 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Day, BW; Du, L; Hossain, MB; Ji, X; Magarian, RA; van der Helm, D | 1 |
Jain, PT; Magarian, RA; Pento, JT | 1 |
Abidi, SM; Dmytryk, JJ; Howard, EW; Pento, JT | 1 |
Balachandran, R; Day, BW; Grant, SG; Welsh, MJ | 1 |
4 other study(ies) available for 1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane and tamoxifen
Article | Year |
---|---|
Structure of 1,1-dichloro-2-(4-methoxyphenyl)-2,3-diphenylcyclopropane.
Topics: Chemical Phenomena; Chemistry, Physical; Crystallization; Cyclopropanes; Estrogen Antagonists; Molecular Structure; Tamoxifen; X-Ray Diffraction | 1992 |
The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.
Topics: Breast Neoplasms; Cell Division; Estradiol; Estrogen Antagonists; Female; Humans; Lung Neoplasms; Microscopy, Electron, Scanning; Microvilli; Protein Binding; Tamoxifen; Tumor Cells, Cultured | 1993 |
The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fibronectins; Fulvestrant; Humans; Neoplasm Invasiveness; Tamoxifen; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1998 |
Z-1,1-Dichloro-2,3-diphenylcyclopropanes block human prostate carcinoma cell proliferation, inhibit prostate-specific antigen expression, and initiate apoptosis.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Growth Inhibitors; Humans; Male; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Tamoxifen; Tumor Cells, Cultured | 2000 |